Immunomic Therapeutics’ is pleased to announce five finalists for the Cancer Discovery Incubator Award.
Immunomic’s unique incubator award offers the selected innovator an opportunity to develop a proof-of-concept experiment in their laboratories. Additionally, the winner will be gifted funding, lab equipment and a unique mentorship with the Immunomic executive team for one year. The goal is to empower the innovator to conduct proof-of-concept experiments and ultimately, help the winner attract funding, partnerships, and fuel growth.